Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Open Med. 2011;5(3):e149-52. Epub 2011 Sep 27.

Ontario's plunging price-caps on generics: deeper dives may drown some drugs.

Author information

  • 1Health Economics in the School of Population and Public Health, University of British Columbia, Vancouver. aslam.anis@ubc.ca

Abstract

In April 2010, the Ontario government announced another reduction in the maximum price of generic drugs permitted under the Ontario Drug Benefit (ODB) program, demanding that generic drugs now be sold for no more than 25% of the branded product's price. Other provinces are following Ontario in setting unprecedentedly low price-caps to reduce the cost of generic drugs. Generic product substitution legislation is vital to reducing costs to provincial drug plans, yet lower and lower price-caps may undo some of the benefits of substitution legislation if generics find it difficult to survive.

PMID:
22046229
[PubMed - indexed for MEDLINE]
PMCID:
PMC3205826
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for PubMed Central
    Loading ...
    Write to the Help Desk